INSMED INC (1INSM.MI) Stock Overview
Europe - BIT:1INSM - US4576693075 - Common Stock
1INSM.MI Key Statistics, Chart & Performance
The current stock price of 1INSM.MI is 141 EUR.
1INSM.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 22.02 | 355.96B | ||
| 1ABBV.MI | ABBVIE INC | 21.97 | 355.08B | ||
| AMG.DE | AMGEN INC | 13.58 | 137.77B | ||
| GIS.DE | GILEAD SCIENCES INC | 15.17 | 125.94B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 24.14 | 90.61B | ||
| ARGX.BR | ARGENX SE | 93.39 | 42.69B | ||
| 1AE.DE | ARGENX SE | 93.04 | 42.53B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.76B | ||
| IDP.DE | BIOGEN INC | 9.18 | 18.63B | ||
| 1EXAS.MI | EXACT SCIENCES CORP | N/A | 9.34B | ||
| 0QF.DE | MODERNA INC | N/A | 9.26B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.25B |
Related stock screener links
About 1INSM.MI
Company Profile
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. The company is headquartered in Bridgewater, New Jersey and currently employs 1,271 full-time employees. The firm is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as drug discovery. Its advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company’s pre-clinical research programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Its first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib, TPIP, and INS1201 as well as pre-clinical research programs.
Company Info
INSMED INC
700 Us Highway 202/206
Bridgewater NEW JERSEY US
Employees: 1271
Phone: 19089779900
INSMED INC / 1INSM.MI FAQ
What is the stock price of INSMED INC today?
The current stock price of 1INSM.MI is 141 EUR.
What is the ticker symbol for INSMED INC stock?
The exchange symbol of INSMED INC is 1INSM and it is listed on the Euronext Milan exchange.
On which exchange is 1INSM.MI stock listed?
1INSM.MI stock is listed on the Euronext Milan exchange.
What is INSMED INC worth?
INSMED INC (1INSM.MI) has a market capitalization of 29.80B EUR. This makes 1INSM.MI a Large Cap stock.
How many employees does INSMED INC have?
INSMED INC (1INSM.MI) currently has 1271 employees.
Is INSMED INC (1INSM.MI) expected to grow?
The Revenue of INSMED INC (1INSM.MI) is expected to grow by 30.36% in the next year. Check the estimates tab for more information on the 1INSM.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INSMED INC (1INSM.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1INSM.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1INSM.MI, evaluating the profitability, health, valuation and growth aspects
- INSMED INC (1INSM.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INSMED INC (1INSM.MI) Sales and EPS estimates to see what analysts future expectations are.
- INSMED INC (1INSM.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INSMED INC (1INSM.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- INSMED INC (1INSM.MI) Stock Chart to make your own analysis
- INSMED INC (1INSM.MI) Latest news and press-releases to stay up to date.
Does INSMED INC (1INSM.MI) stock pay dividends?
1INSM.MI does not pay a dividend.
When does INSMED INC (1INSM.MI) report earnings?
INSMED INC (1INSM.MI) will report earnings on 2025-10-29.
What is the Price/Earnings (PE) ratio of INSMED INC (1INSM.MI)?
INSMED INC (1INSM.MI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.94).
1INSM.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1INSM.MI.
1INSM.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1INSM.MI. 1INSM.MI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
1INSM.MI Financial Highlights
Over the last trailing twelve months 1INSM.MI reported a non-GAAP Earnings per Share(EPS) of -4.94. The EPS decreased by -5.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -41.71% | ||
| ROE | -82.76% | ||
| Debt/Equity | 0.45 |
1INSM.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of -0.54% and a revenue growth 30.36% for 1INSM.MI